Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Check-Cap Ltd Ord (NQ: CHEK )

1.250 USD +0.100 (+8.70%)
Official Closing Price Updated: 7:58 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Check-Cap Ltd Ord

< Previous 1 2 3 Next >
Check-Cap Ltd. Announces Closing of $2.5 Million Registered Direct Offering
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK; CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal... 
From PR Newswire
Check-Cap Ltd. Announces $2.5 Million Registered Direct Offering
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal... 
From PR Newswire
Check-Cap Reports Third Quarter 2017 Financial Results
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK; CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free,... 
From PR Newswire
Check-Cap Announces Acceptance of Late Breaking Clinical Performance Abstract at United European Gastroenterology Week 2017
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK, CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free,... 
From PR Newswire
Check-Cap Announces Filing of CE Mark Registration for C-Scan®
Management Hosts Conference call at 9:00 a.m. EDT 
From PR Newswire
Check-Cap Reports Second Quarter 2017 Financial Results
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK; CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free,... 
From PR Newswire
Check-Cap Ltd. Announces Closing of $2.69 Million Financing
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal... 
From PR Newswire
Check-Cap Ltd. Announces $2.69 Million Financing
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal... 
From PR Newswire
Check-Cap Reports First Quarter 2017 Financial Results
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK; NASDAQ: CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for... 
From PR Newswire
Check-Cap and GE Healthcare Achieve Development Milestone in High-volume X-Ray Capsule Manufacturing Collaboration
Ingestible capsule brings patients one step closer to prep-free, colon screening 
From PR Newswire
Check-Cap Reports Fourth Quarter and Fiscal Year 2016 Financial Results
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal... 
From PR Newswire
Check-Cap to Present at the 29th Annual ROTH Conference on March 14, 2017
From PR Newswire
Check-Cap to Present at the 2nd Annual Disruptive Growth & Healthcare Conference on February 15
From ACCESSWIRE
Life Sciences & Healthcare Investor Conference & Webinar: Nasdaq and OTCQX Companies Present February 2nd
PR Newswire and BetterInvesting (NAIC) today announced the agenda for the upcoming VirtualInvestorConferences.com, the evergreen online investor conference series. Individual investors, institutional... 
From PR Newswire
Check-Cap Ltd. to Webcast, Live, at VirtualInvestorConferences.com on Thursday, February 2
Check-Cap Ltd. (NASDAQ: CHEK), engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening today announced that Bill Densel, CEO, will present live at... 
From PR Newswire
Check-Cap Enrolls First Patient in Clinical Trial to Support CE Mark of Its C-Scan® Colorectal Cancer Screening System
Preparation-free, capsule-based technology has potential to improve colorectal cancer screening rates 
From PR Newswire
PCG Advisory Group (PCG) Announces Clients Participating During the 9th Annual Biotech Showcase(TM) Event and the 35th Annual J.P. Morgan Healthcare Conference in San Francisco
From ACCESSWIRE
Check-Cap Reports Third Quarter 2016 Financial Results
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal... 
From PR Newswire
Check-Cap Announces Presentation of Clinical Data Demonstrating Safety and Detection of Polyps Using Preparation-Free Colorectal Cancer Screening Capsule
- Data presented at the American College of Gastroenterology Annual Scientific Meeting and the United European Gastroenterology Week - 
From PR Newswire
Check-Cap Announces Upcoming Presentations Evaluating Preparation-Free Colorectal Cancer Screening Capsule
- Presentations to take place at the American College of Gastroenterology Annual Scientific Meeting and the United European Gastroenterology Week - 
From PR Newswire
Check-Cap to Present at the Rodman & Renshaw 18th Annual Global Investment Conference on September 13, 2016
Check-Cap Ltd. (Nasdaq: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced... 
From PR Newswire
Check-Cap Reports Second Quarter 2016 Financial Results
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal... 
From PR Newswire
Check-Cap Ltd. Announces $5.9 Million Financing
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal... 
From PR Newswire
Check-Cap Announces Agreement with GE Healthcare for X-Ray Capsule Manufacturing Collaboration
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal... 
From PR Newswire
Check-Cap Awarded $1.25 Million Grant for 2016 From Israel's Office of the Chief Scientist
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal... 
From PR Newswire
Check-Cap Announces Preliminary Data Evaluating its Preparation-Free Colon Screening Capsule
- Results presented at Digestive Disease Week (DDW) 2016 - 
From PR Newswire
Check-Cap Reports First Quarter 2016 Financial Results
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal... 
From PR Newswire
Check-Cap Announces Presentation Evaluating Ingestible Capsule for Preparation-Free Colorectal Cancer Screening at Digestive Disease Week® 2016
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal... 
From PR Newswire
Check-Cap Ltd. Files Annual Report on Form 20-F for the Year Ended December 31, 2015
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal... 
From PR Newswire
Check-Cap Reports Fourth Quarter and Full Year 2015 Financial Results
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal... 
From PR Newswire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.